{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:54:19Z","timestamp":1792299259560,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1124\/jpet.104.067660","type":"journal-article","created":{"date-parts":[[2004,7,16]],"date-time":"2004-07-16T22:43:03Z","timestamp":1090017783000},"page":"656-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver"],"prefix":"10.1016","volume":"310","author":[{"given":"Michael H.","family":"Court","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soundararajan","family":"Krishnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanios","family":"Bekaii-Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Al-Rohaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"von Moltke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.067660_bib1","doi-asserted-by":"crossref","unstructured":"Barbier O, Turgeon D, Girard C, Green MD, Tephly TR, Hum DW, and Belanger A (2000) 3\u2032-Azido-3\u2032-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab Dispos 28: 497\u2013502.","DOI":"10.1016\/S0090-9556(24)15092-1"},{"key":"10.1124\/jpet.104.067660_bib2","doi-asserted-by":"crossref","unstructured":"Bhasker CR, McKinnon W, Stone A, Lo AC, Kubota T, Ishizaki T, and Miners JO (2000) Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 10: 679\u2013685.","DOI":"10.1097\/00008571-200011000-00002"},{"key":"10.1124\/jpet.104.067660_bib3","doi-asserted-by":"crossref","unstructured":"Chen F, Ritter JK, Wang MG, McBride OW, Lubet RA, and Owens IS (1993) Characterization of a cloned human dihydrotestosterone\/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochemistry 32: 10648\u201310657.","DOI":"10.1021\/bi00091a015"},{"key":"10.1124\/jpet.104.067660_bib4","doi-asserted-by":"crossref","unstructured":"Ciotti M, Marrone A, Potter C, and Owens IS (1997) Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 7: 485\u2013495.","DOI":"10.1097\/00008571-199712000-00007"},{"key":"10.1124\/jpet.104.067660_bib5","unstructured":"Coffman BL, King CD, Rios GR, and Tephly TR (1998) The glucuronidation of opioids, other xenobiotics and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos 26: 73\u201377."},{"key":"10.1124\/jpet.104.067660_bib6","doi-asserted-by":"crossref","unstructured":"Court MH, Duan SX, Guillemette C, Journault K, Krishnaswamy S, Von Moltke LL, and Greenblatt DJ (2002) Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9. Drug Metab Dispos 30: 1257\u20131265.","DOI":"10.1124\/dmd.30.11.1257"},{"key":"10.1124\/jpet.104.067660_bib7","doi-asserted-by":"crossref","unstructured":"Court MH, Krishnaswamy S, Hao Q, Duan SX, Patten CJ, Von Moltke LL, and Greenblatt DJ (2003) Evaluation of 3\u2032-azido-3\u2032-deoxythymidine, morphine and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Drug Metab Dispos 31: 1125\u20131133.","DOI":"10.1124\/dmd.31.9.1125"},{"key":"10.1124\/jpet.104.067660_bib8","doi-asserted-by":"crossref","unstructured":"Court MH, Von Moltke LL, Shader RI, and Greenblatt DJ (1997) Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species. Biopharm Drug Dispos 18: 213\u2013226.","DOI":"10.1002\/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO;2-0"},{"key":"10.1124\/jpet.104.067660_bib9","doi-asserted-by":"crossref","unstructured":"Green M, Oturo E, and Tephly T (1994) Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 22: 799\u2013805.","DOI":"10.1016\/S0090-9556(25)07570-1"},{"key":"10.1124\/jpet.104.067660_bib10","doi-asserted-by":"crossref","unstructured":"Greenblatt DJ (1981) Clinical pharmacokinetics of oxazepam and lorazepam. Clin Pharmacokinet 6: 89\u2013105.","DOI":"10.2165\/00003088-198106020-00001"},{"key":"10.1124\/jpet.104.067660_bib11","doi-asserted-by":"crossref","unstructured":"Greenblatt DJ, Abernethy DR, Koepke HH, and Shader RI (1984) Interaction of cimetidine with oxazepam, lorazepam and flurazepam. J Clin Pharmacol 24: 187\u2013193.","DOI":"10.1002\/j.1552-4604.1984.tb01829.x"},{"key":"10.1124\/jpet.104.067660_bib12","doi-asserted-by":"crossref","unstructured":"Greenblatt DJ, Divoll M, Harmatz JS, and Shader RI (1980) Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Ther 215: 86\u201391.","DOI":"10.1016\/S0022-3565(25)32259-7"},{"key":"10.1124\/jpet.104.067660_bib13","doi-asserted-by":"crossref","unstructured":"Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, and Housman DE (2000) Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10: 629\u2013644.","DOI":"10.1097\/00008571-200010000-00006"},{"key":"10.1124\/jpet.104.067660_bib14","doi-asserted-by":"crossref","unstructured":"Holthe M, Klepstad P, Zahlsen K, Borchgrevink PC, Hagen L, Dale O, Kaasa S, Krokan HE, and Skorpen F (2002) Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy. Eur J Clin Pharmacol 58: 353\u2013356.","DOI":"10.1007\/s00228-002-0490-1"},{"key":"10.1124\/jpet.104.067660_bib15","doi-asserted-by":"crossref","unstructured":"Iida A, Saito S, Sekine A, Mishima C, Kitamura Y, Kondo K, Harigae S, Osawa S, and Nakamura Y (2002) Catalog of 86 single-nucleotide polymorphisms (SNPs) in three uridine diphosphate glycosyltransferase genes: UGT2A1, UGT2B15 and UGT8. J Hum Genet 47: 505\u2013510.","DOI":"10.1007\/s100380200075"},{"key":"10.1124\/jpet.104.067660_bib16","doi-asserted-by":"crossref","unstructured":"Jin C, Miners J, Lillywhite K, and Mackenzie P (1993) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphateglucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 264: 475\u2013479.","DOI":"10.1016\/S0022-3565(25)10294-2"},{"key":"10.1124\/jpet.104.067660_bib17","doi-asserted-by":"crossref","unstructured":"Kuuranne T, Kurkela M, Thevis M, Schanzer W, Finel M, and Kostiainen R (2003) Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 31: 1117\u20131124.","DOI":"10.1124\/dmd.31.9.1117"},{"key":"10.1124\/jpet.104.067660_bib18","unstructured":"Lampe JW, Bigler J, Bush AC, and Potter JD (2000) Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y) and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prev 9: 329\u2013333."},{"key":"10.1124\/jpet.104.067660_bib19","doi-asserted-by":"crossref","unstructured":"Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, and Hum DW (1997) Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7: 317\u2013325.","DOI":"10.1097\/00008571-199708000-00007"},{"key":"10.1124\/jpet.104.067660_bib20","unstructured":"Levesque E, Beaulieu M, Hum DW, and Belanger A (1999) Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 9: 207\u2013216."},{"key":"10.1124\/jpet.104.067660_bib21","doi-asserted-by":"crossref","unstructured":"Nishiyama T, Ogura K, Nakano H, Ohnuma T, Kaku T, Hiratsuka A, Muro K, and Watabe T (2002) Reverse geometrical selectivity in glucuronidation and sulfation of cis-and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases. Biochem Pharmacol 63: 1817\u20131830.","DOI":"10.1016\/S0006-2952(02)00994-2"},{"key":"10.1124\/jpet.104.067660_bib22","doi-asserted-by":"crossref","unstructured":"Patel M, Tang BK, Grant DM, and Kalow W (1995a) Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam. Pharmacogenetics 5: 287\u2013297.","DOI":"10.1097\/00008571-199510000-00004"},{"key":"10.1124\/jpet.104.067660_bib23","doi-asserted-by":"crossref","unstructured":"Patel M, Tang BK, and Kalow W (1995b) (S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7. Pharmacogenetics 5: 43\u201349.","DOI":"10.1097\/00008571-199502000-00005"},{"key":"10.1124\/jpet.104.067660_bib24","unstructured":"Schneider S, Roessli D, and Excofier L (2001) Arlequin, in Genetics and Biometry Laboratory. University of Geneva, Geneva, Switzerland."},{"key":"10.1124\/jpet.104.067660_bib25","doi-asserted-by":"crossref","unstructured":"Sonne J (1993) Factors and conditions affecting the glucuronidation of oxazepam. Pharmacol Toxicol 73 (Suppl 1): 1\u201323.","DOI":"10.1111\/j.1600-0773.1993.tb01924.x"},{"key":"10.1124\/jpet.104.067660_bib26","doi-asserted-by":"crossref","unstructured":"Stephens M, Smith NJ, and Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978\u2013989.","DOI":"10.1086\/319501"},{"key":"10.1124\/jpet.104.067660_bib27","doi-asserted-by":"crossref","unstructured":"Yang SK and Lu XL (1989) Racemization kinetics of enantiomeric oxazepams and stereoselective hydrolysis of enantiomeric oxazepam 3-acetates in rat liver microsomes and brain homogenate. J Pharm Sci 78: 789\u2013795.","DOI":"10.1002\/jps.2600781002"},{"key":"10.1124\/jpet.104.067660_bib28","doi-asserted-by":"crossref","unstructured":"Zhang JY, Zhan J, Cook CS, Ings RM, and Breau AP (2003) Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. Drug Metab Dispos 31: 652\u2013658.","DOI":"10.1124\/dmd.31.5.652"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524314831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524314831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.067660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:57:03Z","timestamp":1739998623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524314831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0022356524314831"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.067660","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.067660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}